Search filters

List of works by Suzanne L. Topalian

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

scientific article

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

scientific article

Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines

scientific article

Antagonists of PD-1 and PD-L1 in Cancer Treatment

scientific article

Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy

scientific article published on 23 March 2017

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

scientific article

Balance and imbalance in the immune system: life on the edge

scientific article

Cancer immunotherapy comes of age

scientific article published on 31 October 2011

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

scientific article

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

scientific article

Cancer regression in patients after transfer of genetically engineered lymphocytes

scientific article

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma

scientific article published on September 2003

Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas

scientific article published on 30 October 2020

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

scientific article (publication date: 28 March 2012)

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 ⬇️

scientific article published on August 25, 2011

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

scientific article

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

scientific article

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

scientific article

Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma

scientific article

Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy

scientific article

Immune checkpoint blockade: a common denominator approach to cancer therapy

scientific article

Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen

scientific article

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

scientific article

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

scientific article

Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma

scientific article

Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis

scientific article

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

scientific article

Mechanisms regulating PD-L1 expression on tumor and immune cells

scientific article published on 15 November 2019

Meeting report: The future of preclinical mouse models in melanoma treatment is now.

scientific article

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Neoadjuvant Therapy for Melanoma: A US Food and Drug Administration - Melanoma Research Alliance Public Workshop

scientific article published on 13 November 2020

Neoadjuvant checkpoint blockade for cancer immunotherapy

scientific article published on 01 January 2020

Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer ⬇️

scientific article published on July 15, 2011

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

scientific article

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

scientific article

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

scientific article published on 31 October 2019

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

scientific article

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

scientific article

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma

scientific article

Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme.

scientific article

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

scientific article (publication date: 28 June 2012)

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

scientific article published on 5 July 2015

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer ⬇️

scientific article published on June 2, 2012

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule

scientific article published on 21 June 2016

Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells

scientific article

Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor

scientific article

Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3

scientific article

Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity

scientific article

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

scientific article published on 30 March 2015

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity ⬇️

scientific article published on January 9, 2012

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy

scientific article published on 21 July 2017

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma

scientific article published on 4 August 2016

The genetic evolution of treatment-resistant cutaneous, acral and uveal melanomas

scientific article published on 15 December 2020

Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.

scientific article published on 13 February 2017

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

scientific article

Paulina is supported by:

About Paulina

Help